Contact Us Investor Relations Site Map
 
產品服務單元情境圖
Announcements Home > Investor Relations > Announcements
回列表
Announcement of Consolidated Revenue Correction again in December Date of announcement: 2023/02/24
SEQ_NO.3Time of announcement:16:35:33Date of events:2023/2/24To which item it meets:paragraph 51
Spokesman:Sun,Yin-NanTitle of spokesman:Vice PresidentTelephone no. of spokesman:02-23124200
Statement

Statement
1.Date of occurrence of the event:2023/02/24
2.Company name:China Chemical & Pharmaceutical Co., Ltd.
3.Relationship with the Company (please enter ”the company itself”
or ”subsidiaries”):the company itself
4.Reciprocal shareholding percentage:N/A
5.Cause of occurrence:The consolidated revenue is adjusted due to the
adjustment of the company's branch sales figures.
6.Information items/ statements to be corrected:revenue
7.Amounts/ contents/ number of page to be corrected:NT$736,352,000 and
consolidated self-consolidated revenue:NT$8,258,990,000 from January
to December
8.Amounts/ contents/ number of page after correction:NT$933,515,000 and
consolidated self-consolidated revenue:NT$8,456,153,000 from January
to December.
9.Countermeasures:Published major information on TWSE MOPS and corrected
revenue announcement of Dec 2022
10.Any other matters that need to be specified:N/A

 
中文版 ENGLISH
 
 
泭第 忒儂泭 泭 忒儂潼泭